Education
About Us
Working with TipRanks
Follow Us
Jubilant Ingrevia Ltd. (IN:JUBLINGREA)
:JUBLINGREA
JUBLINGREA Stock Chart & Stats
₹726.00
-₹47.65(-5.70%)
At close: 4:00 PM EST
₹726.00
-₹47.65(-5.70%)
Day’s Range― - ―
52-Week Range₹535.30 - ₹851.85
Previous CloseN/A
Volume517.05K
Average Volume (3M)13.09K
Market Cap
₹90.68B
Enterprise Value₹97.48B
Total Cash (Recent Filing)₹1.15B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)34.8
Beta1.00
Next Earnings
May 19, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.74%
Share Statistics
EPS (TTM)3.00
Shares Outstanding159,281,140
10 Day Avg. Volume10,350
30 Day Avg. Volume13,091
Financial Highlights & Ratios
PEG Ratio1.10
Price to Book (P/B)3.53
Price to Sales (P/S)2.47
P/FCF Ratio72.61
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)18.02
Revenue Forecast (FY)₹44.31B
Bulls Say, Bears Say
Bulls Say
Integrated Manufacturing & Diversified ProductsJubilant Ingrevia’s combination of chemical synthesis and fermentation gives structural advantages: it can supply both specialty chemicals and bio-based nutrition ingredients, capture higher-value product mixes, and offer reliable, integrated supply to B2B customers. This supports durable contract relationships, margin resilience, and cross-segment cost synergies that remain relevant over multiple quarters.
Stable Profitability And MarginsConsistently stable EBIT/EBITDA margins indicate efficient operations and pricing power in specialty chemical and ingredient markets. Sustained margin performance underpins long-term earnings durability by absorbing input cost swings, enabling reinvestment in R&D and capacity, and supporting resilient operating cash flow over 2–6 months and beyond.
Improved Operating Cash Flow & Positive FCF TrendA recent improvement to positive free cash flow and consistently strong operating cash flow enhances financial flexibility: it supports funding for targeted capex, debt servicing, and strategic investments without reliance on external financing. That strengthens balance-sheet durability and the company’s ability to execute long-term growth plans.
Bears Say
Revenue Volatility, 2024 DipIntermittent revenue declines demonstrate sensitivity to end-market cycles and demand for intermediates and nutrition ingredients. Such volatility can pressure utilization, margin leverage, and cash generation during downturns, requiring conservative planning and potentially delaying investments or contract expansion over the medium term.
Rising Total LiabilitiesGrowth in total liabilities increases leverage risk and reduces financial flexibility if top-line momentum weakens. Higher liabilities can constrain capital allocation choices, raise interest exposure over time, and make the company more vulnerable to cost-of-capital shocks, which matters for multi-quarter resilience and strategic optionality.
Prior Negative Free Cash Flow PeriodsHistoric negative free cash flow in some periods indicates past difficulty balancing capex with operating cash generation. If capex requirements rise (capacity, compliance, or upgrades), recurrence of negative FCF could strain liquidity and limit reinvestment, making long-term growth and margin maintenance more dependent on execution and disciplined capital spending.
Jubilant Ingrevia Ltd. News
JUBLINGREA FAQ
What was Jubilant Ingrevia Ltd.’s price range in the past 12 months?
Jubilant Ingrevia Ltd. lowest stock price was ₹535.30 and its highest was ₹851.85 in the past 12 months.
What is Jubilant Ingrevia Ltd.’s market cap?
Jubilant Ingrevia Ltd.’s market cap is ₹90.68B.
When is Jubilant Ingrevia Ltd.’s upcoming earnings report date?
Jubilant Ingrevia Ltd.’s upcoming earnings report date is May 19, 2026 which is in 77 days.
How were Jubilant Ingrevia Ltd.’s earnings last quarter?
Jubilant Ingrevia Ltd. released its earnings results on Feb 04, 2026. The company reported ₹3 earnings per share for the quarter, missing the consensus estimate of ₹3.5 by -₹0.5.
Is Jubilant Ingrevia Ltd. overvalued?
According to Wall Street analysts Jubilant Ingrevia Ltd.’s price is currently Overvalued.
Does Jubilant Ingrevia Ltd. pay dividends?
Jubilant Ingrevia Ltd. pays a Semiannually dividend of ₹2.5 which represents an annual dividend yield of 0.74%. See more information on Jubilant Ingrevia Ltd. dividends here
What is Jubilant Ingrevia Ltd.’s EPS estimate?
Jubilant Ingrevia Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Jubilant Ingrevia Ltd. have?
Jubilant Ingrevia Ltd. has 159,281,140 shares outstanding.
What happened to Jubilant Ingrevia Ltd.’s price movement after its last earnings report?
Jubilant Ingrevia Ltd. reported an EPS of ₹3 in its last earnings report, missing expectations of ₹3.5. Following the earnings report the stock price went down -1.778%.
Which hedge fund is a major shareholder of Jubilant Ingrevia Ltd.?
Currently, no hedge funds are holding shares in IN:JUBLINGREA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Jubilant Ingrevia Ltd.
Jubilant Ingrevia Limited provides life science products and solutions in India and internationally. It operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Life Science Chemicals. The Specialty Chemicals segment offers specialty ingredients, fine chemicals, crop protection chemicals, and custom development and manufacturing services. The Nutrition & Health Solutions segment provides nutrition and health ingredients, animal nutrition and health solutions, and human nutrition and health solutions. The Life Science Chemicals offers life science ingredients and specialty ethanol. The company also offers pyridine and picolines, cyanopyridines, piperidines, acetyl pyridines, amino pyridines, halo pyridines, pyridine aldehydes, metal complexes, amino pyridines, halogenated pyridines, quaternary salts, alkyl pyridines, vitamin B3 and picolinates, riboflavin phosphate sodium, nutritional premixes, antioxidants, straight ingredients, acetic anhydride, acetic acid, ethyl acetate, propionic anhydride, absolute alcohol, ethanol, biocompost, CO2 and ETO mixtures. In addition, it provides route design, process development, process optimization, and scale-up and commercial manufacturing of intermediates. Further, the company offers vitamins, mineral premixes, stress regulator, amino acid, herbal choline, herbal non-antibiotic growth promoter and egg quality enhancer, toxin binder, acidifiers, and enzymes and emulsifiers. It serves pharmaceutical, nutrition, agrochemical, consumer, and industrial customers. The company was formerly known as Jubilant LSI Limited and changed its name to Jubilant Ingrevia Limited in October 2020. Jubilant Ingrevia Limited was incorporated in 2019 and is based in Noida, India.
Technical Analysis
Alkyl Amines Chemicals Limited
―
―
Anupam Rasayan India Ltd.
―
Privi Speciality Chemicals Limited
―
Sudarshan Chemical Industries Limited
―